4.8 Article

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies

Zhaoyang Li et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Multidisciplinary Sciences

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance

Antonina V. Kurtova et al.

NATURE (2015)

Article Medicine, Research & Experimental

Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth

Thanh U. Barbie et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Cell Biology

A cell-intrinsic role for TLR2 MYD88 in intestinal and breast epithelia and oncogenesis

Ferenc A. Scheeren et al.

NATURE CELL BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu et al.

NATURE MEDICINE (2014)

Article Multidisciplinary Sciences

Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade

Xuefeng Wu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Multidisciplinary Sciences

被撤回的出版物: Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells (Retracted article. See vol. 119, 2022)

Debangshu Samanta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Oncology

Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome

Garrett W. Rhyasen et al.

CANCER CELL (2013)

Article Medicine, Research & Experimental

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

Neil E. Bhola et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Oncology

Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4

Ratika Srivastava et al.

CANCER RESEARCH (2012)

Article Biochemistry & Molecular Biology

A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

Swarnali Acharyya et al.

Review Immunology

NF-κB and the link between inflammation and cancer

Joseph A. DiDonato et al.

IMMUNOLOGICAL REVIEWS (2012)

Article Biochemical Research Methods

NIH Image to ImageJ: 25 years of image analysis

Caroline A. Schneider et al.

NATURE METHODS (2012)

Article Pharmacology & Pharmacy

Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-The key step of inflammation

Eun-Ha Joh et al.

BIOCHEMICAL PHARMACOLOGY (2011)

Article Medicine, Research & Experimental

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors

Lauren L. C. Marotta et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Biochemistry & Molecular Biology

Mcl-1; the molecular regulation of protein function

Luke W. Thomas et al.

FEBS LETTERS (2010)

Article Medicine, Research & Experimental

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

Christophe Ginestier et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Review Medicine, General & Internal

Triple-Negative Breast Cancer

William D. Foulkes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Biotechnology & Applied Microbiology

OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls

Veronique Baud et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Review Oncology

Toll-like receptors and cancer

Seth Rakoff-Nahoum et al.

NATURE REVIEWS CANCER (2009)

Article Cell Biology

Targeting cancer stem cells in cancer prevention and therapy

Prithi Rajan et al.

STEM CELL REVIEWS (2008)

Review Oncology

Triple-negative breast cancer: therapeutic options

Susan Cleator et al.

LANCET ONCOLOGY (2007)

Review Biochemistry & Molecular Biology

Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression

D. S. Basseres et al.

ONCOGENE (2006)

Review Biochemistry & Molecular Biology

Current insights into the regulation of programmed cell death by NF-κB

J. Dutta et al.

ONCOGENE (2006)

Article Biochemistry & Molecular Biology

p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65

Beibei Cai et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Medicine, Research & Experimental

IKK/NF-κB signaling: balancing life and death -: a new approach to cancer therapy

JL Luo et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Multidisciplinary Sciences

Genes that mediate breast cancer metastasis to lung

AJ Minn et al.

NATURE (2005)

Review Biochemistry & Molecular Biology

Mitogen-activated protein kinases in apoptosis regulation

T Wada et al.

ONCOGENE (2004)

Article Biochemistry & Molecular Biology

IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression

YS Huang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)

Article Medicine, General & Internal

A gene-expression signature as a predictor of survival in breast cancer.

MJ van de Vijver et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)